Specialty Pharmacy & Distribution

UBC - April 02, 2013
Less than one percent of the U.S. population uses specialty therapies, yet specialty drugs receive significant resources and development from pharma manufacturers.  Last year marked the third consecutive year specialty drugs made...
UBC - March 18, 2013
Patients living with hereditary angioedema (HAE) need to be prepared with an appropriate treatment plan. HAE is a very rare and potentially life threatening genetic condition that occurs in 1 in 10,000 to 1 in 50,000 people. Symptoms...
UBC - February 21, 2013
Next week’s Pinsonault Managed Markets Summit – Spring Meeting will host executives from leading healthcare organizations, including UBC, who’ll be sharing their knowledge and expertise.  Here’s a lineup of our staff and their...
, Vice President, Business Development - January 09, 2013
We all welcomed the news when the U.S. Food and Drug Administration (FDA) approved Gattex® (Teduglutide [rDNA origin]) for Injection, for subcutaneous use for the treatment of adult patients with short bowel syndrome (SBS) who are...
, Vice President, Global Pharmaceutical Business Development - January 02, 2013
While we would all like highly customized programs for our favorite products, the fact is not all products require a full spectrum of specialized services. Sometimes a product just needs a little something extra… You see, not every...

Pages